TGFB1 and breast carcinoma: Militating against this possibility are the facts that the TGF-β pathway is not over-represented in UC/DB transcripts, and other investigations did not find evidence for the regulation of TGF-β genes/proteins by tamoxifen in breast cancer patients [48].